scPharmaceuticals entered into a binding term sheet with respect to a $100 million secured debt facility with funds managed by Oaktree Capital Management.
Oxford Biomedica, a gene and cell therapy group, refinanced the $85 million secured 12-month loan facility from funds managed by Oaktree Capital Management.
Itafos entered into credit facilities with a syndicate of lenders led by RBC Capital Markets, pursuant to which the lenders have advanced an $85 million term loan to the company and made available a $35 million letter of credit facility and an $80 million asset-based revolving credit facility.
Establishment Labs, a medical technology company focused on women’s health initially in the breast aesthetics and reconstruction market, entered into a $225 million term loan financing facility with funds managed by Oaktree Capital Management.
Marinus Pharmaceuticals, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, received $30 million in funding under its existing credit agreement with Oaktree Capital Management.
Oaktree Capital Management closed two separate transactions totaling $100 million in gross funding for Impel NeuroPharma, a commercial-stage pharmaceutical company. The transactions include $50 million of senior secured debt.
NN, a diversified industrial company, amended its five-and-a-half-year, $150 million term loan with funds managed by Oaktree Capital Management.
Innocoll Biotherapeutics, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, successfully refinanced its existing term loan facility with a $125 million term loan provided by funds managed by Oaktree Capital Management.
Funds managed by Oaktree Capital Management, a global investment manager specializing in alternative investments, acquired Velocity Risk Underwriters, a catastrophe-focused property and specialty insurance risk managing general agent.
Vmo Aircraft Leasing increased its capital base from $500 million to $1.1 billion through its latest round of fundraising. Ares Alternative Credit Group, funds managed by Oaktree Capital Management and Diameter Capital Partners provided the capital injection.